Catalyst Brief

← Calendar

Readoutin 45d

Lexicon Pharmaceuticals — Sotagliflozin

Phase 3 primary completion: A Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obstructive and Non-obstructive Hypertrophic Cardiomyopathy.

Date
Jan 2027
Type
Readout
Indication
Obstructive Cardiomyopathy, Hypertrophic

Source ↗Add to calendar

Get told when this date moves

The weekly brief is free. Pro adds reminders 7 days and 1 day before.